Zhejiang Xinguang Pharmaceutical Co Ltd
Zhejiang Xinguang Pharmaceutical Co., Ltd. engages in the research and development, production, and sales of Chinese patent medicines, chemical medicines, and health food in China. It offers pharmaceutical products that cover respiratory, digestive, and urinary systems, as well as cardiovascular, cerebrovascular, trauma, and pediatric diseases. The company was incorporated in 1998 and is headquar… Read more
Market Cap & Net Worth: Zhejiang Xinguang Pharmaceutical Co Ltd (300519)
Zhejiang Xinguang Pharmaceutical Co Ltd (SHE:300519) has a market capitalization of $356.54 Million (CN¥2.62 Billion) as of March 19, 2026. Listed on the SHE stock exchange, this China-based company holds position #16049 globally and #4278 in its home market, demonstrating a -0.30% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Zhejiang Xinguang Pharmaceutical Co Ltd's stock price CN¥16.35 by its total outstanding shares 160000000 (160.00 Million).
Zhejiang Xinguang Pharmaceutical Co Ltd Market Cap History: 2016 to 2026
Zhejiang Xinguang Pharmaceutical Co Ltd's market capitalization history from 2016 to 2026. Data shows growth from $723.28 Million to $356.54 Million (8.80% CAGR).
Zhejiang Xinguang Pharmaceutical Co Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Zhejiang Xinguang Pharmaceutical Co Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
1.08x
Zhejiang Xinguang Pharmaceutical Co Ltd's market cap is 1.08 times its annual revenue
1.00x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
5.74x
Zhejiang Xinguang Pharmaceutical Co Ltd's market cap is 5.74 times its annual earnings
9.89x
Lower than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $723.28 Million | $315.31 Million | $118.96 Million | 2.29x | 6.08x |
| 2017 | $355.55 Million | $310.87 Million | $106.16 Million | 1.14x | 3.35x |
| 2018 | $251.12 Million | $276.26 Million | $88.00 Million | 0.91x | 2.85x |
| 2019 | $251.16 Million | $291.26 Million | $93.90 Million | 0.86x | 2.67x |
| 2020 | $306.23 Million | $283.08 Million | $98.98 Million | 1.08x | 3.09x |
| 2021 | $399.45 Million | $320.88 Million | $114.28 Million | 1.24x | 3.50x |
| 2022 | $321.18 Million | $351.49 Million | $108.82 Million | 0.91x | 2.95x |
| 2023 | $349.89 Million | $270.40 Million | $64.36 Million | 1.29x | 5.44x |
| 2024 | $289.37 Million | $267.66 Million | $50.39 Million | 1.08x | 5.74x |
Competitor Companies of 300519 by Market Capitalization
Companies near Zhejiang Xinguang Pharmaceutical Co Ltd in the global market cap rankings as of March 19, 2026.
Key companies related to Zhejiang Xinguang Pharmaceutical Co Ltd by market ranking:
- Zoetis Inc (NYSE:ZTS): Ranked #422 globally with a market cap of $51.61 Billion USD.
- Haleon plc (NYSE:HLN): Ranked #432 globally with a market cap of $49.87 Billion USD.
- Takeda Pharmaceutical Co. Ltd. (PINK:TKPHF): Ranked #452 globally with a market cap of $47.47 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #719 globally with a market cap of $28.19 Billion USD ( CN¥206.84 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #422 | Zoetis Inc | NYSE:ZTS | $51.61 Billion | $117.35 |
| #432 | Haleon plc | NYSE:HLN | $49.87 Billion | $10.31 |
| #452 | Takeda Pharmaceutical Co. Ltd. | PINK:TKPHF | $47.47 Billion | $30.07 |
| #719 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $28.19 Billion | CN¥55.11 |
Zhejiang Xinguang Pharmaceutical Co Ltd Historical Marketcap From 2016 to 2026
Between 2016 and today, Zhejiang Xinguang Pharmaceutical Co Ltd's market cap moved from $723.28 Million to $ 356.54 Million, with a yearly change of 8.80%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥356.54 Million | +9.73% |
| 2025 | CN¥324.92 Million | +12.28% |
| 2024 | CN¥289.37 Million | -17.30% |
| 2023 | CN¥349.89 Million | +8.94% |
| 2022 | CN¥321.18 Million | -19.59% |
| 2021 | CN¥399.45 Million | +30.44% |
| 2020 | CN¥306.23 Million | +21.93% |
| 2019 | CN¥251.16 Million | +0.01% |
| 2018 | CN¥251.12 Million | -29.37% |
| 2017 | CN¥355.55 Million | -50.84% |
| 2016 | CN¥723.28 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 19th, 2026 the market cap of Zhejiang Xinguang Pharmaceutical Co Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $356.54 Million USD |
| MoneyControl | $356.54 Million USD |
| MarketWatch | $356.54 Million USD |
| marketcap.company | $356.54 Million USD |
| Reuters | $356.54 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.